HEADER OXIDOREDUCTASE 31-OCT-09 2WX2 TITLE X-RAY STRUCTURE OF CYP51 FROM THE HUMAN PATHOGEN TRYPANOSOMA CRUZI IN TITLE 2 COMPLEX WITH FLUCONAZOLE COMPND MOL_ID: 1; COMPND 2 MOLECULE: LANOSTEROL 14-ALPHA-DEMETHYLASE; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: RESIDUES 22-481; COMPND 5 SYNONYM: CYP51; COMPND 6 EC: 1.14.13.70; COMPND 7 ENGINEERED: YES; COMPND 8 OTHER_DETAILS: FIRST 20 RESIDUES UPSTREAM OF K21 WERE REPLACED WITH COMPND 9 THE FRAGMENT MAKKKKK SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: TRYPANOSOMA CRUZI; SOURCE 3 ORGANISM_TAXID: 5693; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 6 EXPRESSION_SYSTEM_STRAIN: HMS174(DE3); SOURCE 7 EXPRESSION_SYSTEM_VECTOR: PCWORI; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PCWORI KEYWDS P450, HEME, IRON, METAL-BINDING, METHYLTRANSFERASE, ERGOSTEROL KEYWDS 2 BIOSYNTHESIS, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR C.-K.CHEN,S.S.F.LEUNG,C.GUILBERT,M.JACOBSON,J.H.MCKERROW,L.M.PODUST REVDAT 5 20-DEC-23 2WX2 1 REMARK LINK REVDAT 4 11-APR-12 2WX2 1 JRNL REMARK VERSN HETSYN REVDAT 3 07-APR-10 2WX2 1 JRNL REMARK REVDAT 2 02-FEB-10 2WX2 1 JRNL REMARK MASTER REVDAT 1 10-NOV-09 2WX2 0 JRNL AUTH C.-K.CHEN,S.S.F.LEUNG,C.GUILBERT,M.JACOBSON,J.H.MCKERROW, JRNL AUTH 2 L.M.PODUST JRNL TITL STRUCTURAL CHARACTERIZATION OF CYP51 FROM TRYPANOSOMA CRUZI JRNL TITL 2 AND TRYPANOSOMA BRUCEI BOUND TO THE ANTIFUNGAL DRUGS JRNL TITL 3 POSACONAZOLE AND FLUCONAZOLE JRNL REF PLOS NEGL TROP DIS V. 4 E651 2010 JRNL REFN ISSN 1935-2727 JRNL PMID 20386598 JRNL DOI 10.1371/JOURNAL.PNTD.0000651 REMARK 2 REMARK 2 RESOLUTION. 2.27 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0072 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.27 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 69.50 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 89.1 REMARK 3 NUMBER OF REFLECTIONS : 38067 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.197 REMARK 3 R VALUE (WORKING SET) : 0.193 REMARK 3 FREE R VALUE : 0.273 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 1944 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.27 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.33 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1604 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 50.78 REMARK 3 BIN R VALUE (WORKING SET) : 0.2030 REMARK 3 BIN FREE R VALUE SET COUNT : 81 REMARK 3 BIN FREE R VALUE : 0.3640 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6943 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 130 REMARK 3 SOLVENT ATOMS : 429 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 31.80 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 23.75 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.17000 REMARK 3 B22 (A**2) : -0.05000 REMARK 3 B33 (A**2) : 0.55000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.91000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.291 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.201 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 18.013 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.936 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.872 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 7273 ; 0.016 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 9895 ; 1.736 ; 2.009 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 881 ; 6.510 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 314 ;36.902 ;23.280 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1200 ;18.953 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 53 ;18.536 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 1073 ; 0.117 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 5543 ; 0.008 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 4438 ; 0.851 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 7170 ; 1.463 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2835 ; 2.326 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2725 ; 3.560 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): 7273 ; 1.483 ; 3.000 REMARK 3 SPHERICITY; FREE ATOMS (A**2): 430 ; 6.576 ; 3.000 REMARK 3 SPHERICITY; BONDED ATOMS (A**2): 7084 ; 2.308 ; 3.000 REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. DISORDERED REGIONS WERE OMITTED FROM THE STRUCTURE REMARK 4 REMARK 4 2WX2 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 31-OCT-09. REMARK 100 THE DEPOSITION ID IS D_1290041593. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 23-OCT-09 REMARK 200 TEMPERATURE (KELVIN) : 110 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 8.3.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.11587 REMARK 200 MONOCHROMATOR : SI (111) DOUBLE CRYSTAL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 40051 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.270 REMARK 200 RESOLUTION RANGE LOW (A) : 24.300 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 3.600 REMARK 200 R MERGE (I) : 0.09000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.27 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.39 REMARK 200 COMPLETENESS FOR SHELL (%) : 55.7 REMARK 200 DATA REDUNDANCY IN SHELL : 2.40 REMARK 200 R MERGE FOR SHELL (I) : 0.42000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: REFMAC REMARK 200 STARTING MODEL: PDB ENTRY 2WUZ REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.30 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 25% PEG 4000, 0.1 M BIS-TRIS, PH 5.5 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 50.73600 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 15 REMARK 465 ALA A 16 REMARK 465 LYS A 17 REMARK 465 LYS A 18 REMARK 465 LYS A 19 REMARK 465 LYS A 20 REMARK 465 LYS A 21 REMARK 465 LYS A 22 REMARK 465 SER A 23 REMARK 465 PHE A 24 REMARK 465 ASN A 25 REMARK 465 GLN A 225 REMARK 465 SER A 226 REMARK 465 ALA A 227 REMARK 465 GLU A 251 REMARK 465 ALA A 252 REMARK 465 SER A 253 REMARK 465 LYS A 254 REMARK 465 ASP A 255 REMARK 465 ASN A 256 REMARK 465 ASN A 257 REMARK 465 THR A 258 REMARK 465 LYS A 478 REMARK 465 LEU A 479 REMARK 465 PRO A 480 REMARK 465 SER A 481 REMARK 465 HIS A 482 REMARK 465 HIS A 483 REMARK 465 HIS A 484 REMARK 465 HIS A 485 REMARK 465 HIS A 486 REMARK 465 HIS A 487 REMARK 465 MET B 15 REMARK 465 ALA B 16 REMARK 465 LYS B 17 REMARK 465 LYS B 18 REMARK 465 LYS B 19 REMARK 465 LYS B 20 REMARK 465 LYS B 21 REMARK 465 LYS B 22 REMARK 465 SER B 23 REMARK 465 PHE B 24 REMARK 465 ASN B 25 REMARK 465 THR B 26 REMARK 465 THR B 27 REMARK 465 SER B 202 REMARK 465 LYS B 203 REMARK 465 MET B 204 REMARK 465 GLU B 205 REMARK 465 SER B 206 REMARK 465 GLU B 250 REMARK 465 GLU B 251 REMARK 465 ALA B 252 REMARK 465 SER B 253 REMARK 465 LYS B 254 REMARK 465 ASP B 255 REMARK 465 ASN B 256 REMARK 465 ASN B 257 REMARK 465 THR B 258 REMARK 465 HIS B 486 REMARK 465 HIS B 487 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 THR A 26 OG1 CG2 REMARK 470 GLU A 54 CD OE1 OE2 REMARK 470 ILE A 136 CG1 CG2 CD1 REMARK 470 GLN A 140 CD OE1 NE2 REMARK 470 ASN A 141 CG OD1 ND2 REMARK 470 GLU A 156 CG CD OE1 OE2 REMARK 470 GLU A 160 CG CD OE1 OE2 REMARK 470 LYS A 190 CE NZ REMARK 470 LYS A 203 CG CD CE NZ REMARK 470 SER A 206 OG REMARK 470 MET A 215 CG SD CE REMARK 470 LEU A 219 CG CD1 CD2 REMARK 470 ARG A 228 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 230 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 248 CG CD OE1 OE2 REMARK 470 LYS A 249 CG CD CE NZ REMARK 470 GLU A 250 CG CD OE1 OE2 REMARK 470 SER A 259 OG REMARK 470 ARG A 275 NE CZ NH1 NH2 REMARK 470 LYS A 311 CE NZ REMARK 470 LYS A 368 CE NZ REMARK 470 LYS A 421 CE NZ REMARK 470 LYS A 477 CG CD CE NZ REMARK 470 ARG B 28 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 50 CE NZ REMARK 470 ARG B 61 NE CZ NH1 NH2 REMARK 470 ARG B 100 NE CZ NH1 NH2 REMARK 470 ILE B 105 CG1 CG2 CD1 REMARK 470 ASN B 141 CG OD1 ND2 REMARK 470 LYS B 159 CD CE NZ REMARK 470 LYS B 190 CE NZ REMARK 470 ARG B 195 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 220 CG CD NE CZ NH1 NH2 REMARK 470 GLN B 225 CG CD OE1 NE2 REMARK 470 SER B 226 OG REMARK 470 LYS B 238 CG CD CE NZ REMARK 470 LYS B 249 CG CD CE NZ REMARK 470 SER B 259 OG REMARK 470 LYS B 368 CE NZ REMARK 470 LYS B 477 CG CD CE NZ REMARK 470 LYS B 478 CE NZ REMARK 470 HIS B 483 CG ND1 CD2 CE1 NE2 REMARK 470 HIS B 484 CG ND1 CD2 CE1 NE2 REMARK 470 HIS B 485 CG ND1 CD2 CE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O VAL A 269 O THR A 274 1.93 REMARK 500 O PHE B 184 NH1 ARG B 189 1.93 REMARK 500 O VAL A 114 OE1 GLN A 126 1.93 REMARK 500 OD2 ASP B 324 O HOH B 2119 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU B 223 CA - CB - CG ANGL. DEV. = 14.9 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 64 46.74 35.12 REMARK 500 ILE A 72 -85.10 -83.86 REMARK 500 ALA A 115 -89.87 -136.09 REMARK 500 GLN A 140 -71.41 -8.70 REMARK 500 TRP A 158 54.59 -111.29 REMARK 500 GLU A 205 18.41 -62.79 REMARK 500 LEU A 219 174.08 -57.87 REMARK 500 ASP A 260 -167.40 -79.31 REMARK 500 VAL A 269 -67.01 -103.74 REMARK 500 TYR A 270 149.34 107.23 REMARK 500 LYS A 376 130.76 -39.37 REMARK 500 ILE A 413 22.49 -142.81 REMARK 500 LEU A 448 43.62 -96.60 REMARK 500 ASP B 31 134.18 -26.20 REMARK 500 LYS B 64 55.89 30.78 REMARK 500 ALA B 115 -119.86 48.44 REMARK 500 TYR B 120 136.68 -39.59 REMARK 500 GLN B 140 -46.07 -28.63 REMARK 500 TRP B 158 52.51 -104.87 REMARK 500 LEU B 192 86.48 -154.77 REMARK 500 PRO B 327 165.97 -49.60 REMARK 500 HIS B 484 172.52 152.68 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2019 DISTANCE = 6.06 ANGSTROMS REMARK 525 HOH A2048 DISTANCE = 6.46 ANGSTROMS REMARK 525 HOH B2031 DISTANCE = 5.81 ANGSTROMS REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 PROTOPORPHYRIN IX CONTAINING FE (HEM): THIOLATE BOND REMARK 600 BETWEEN THE HEME IRON AND CYS 422 REMARK 600 FLUCONAZOLE (TPF): COORDINATION BOND TO THE HEME IRON REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM A1450 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A 422 SG REMARK 620 2 HEM A1450 NA 99.8 REMARK 620 3 HEM A1450 NB 90.0 83.3 REMARK 620 4 HEM A1450 NC 83.5 176.5 95.7 REMARK 620 5 HEM A1450 ND 91.0 97.5 178.5 83.5 REMARK 620 6 TPF A1460 N5 173.1 87.0 91.8 89.7 87.1 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM B1450 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS B 422 SG REMARK 620 2 HEM B1450 NA 92.2 REMARK 620 3 HEM B1450 NB 86.3 91.1 REMARK 620 4 HEM B1450 NC 89.3 178.6 89.3 REMARK 620 5 HEM B1450 ND 92.8 88.0 178.7 91.7 REMARK 620 6 TPF B1460 N5 175.7 88.5 89.4 90.1 91.5 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEM A 1450 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TPF A 1460 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEM B 1450 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TPF B 1460 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2WV2 RELATED DB: PDB REMARK 900 X-RAY STRUCTURE OF CYP51 FROM THE HUMAN PATHOGEN TRYPANOSOMA BRUCEI REMARK 900 IN COMPLEX WITH FLUCONAZOLE REMARK 900 RELATED ID: 2WUZ RELATED DB: PDB REMARK 900 X-RAY STRUCTURE OF CYP51 FROM TRYPANOSOMA CRUZI IN COMPLEX WITH REMARK 900 FLUCONAZOLE IN ALTERNATIVE CONFORMATION REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE FIRST 21 RESIDUES UPSTREAM OF K22 WERE REPLACED WITH REMARK 999 THE FRAGMENT MAKKKKK AT THE N-TERMINUS. HIS6-TAG WAS REMARK 999 INTRODUCED AT THE C-TERMINUS DBREF 2WX2 A 15 21 PDB 2WX2 2WX2 15 21 DBREF 2WX2 A 22 481 UNP Q7Z1V1 Q7Z1V1_TRYCR 22 481 DBREF 2WX2 A 482 487 PDB 2WX2 2WX2 482 487 DBREF 2WX2 B 15 21 PDB 2WX2 2WX2 15 21 DBREF 2WX2 B 22 481 UNP Q7Z1V1 Q7Z1V1_TRYCR 22 481 DBREF 2WX2 B 482 487 PDB 2WX2 2WX2 482 487 SEQRES 1 A 473 MET ALA LYS LYS LYS LYS LYS LYS SER PHE ASN THR THR SEQRES 2 A 473 ARG PRO THR ASP PRO PRO VAL TYR PRO VAL THR VAL PRO SEQRES 3 A 473 PHE LEU GLY HIS ILE VAL GLN PHE GLY LYS ASN PRO LEU SEQRES 4 A 473 GLU PHE MET GLN ARG CYS LYS ARG ASP LEU LYS SER GLY SEQRES 5 A 473 VAL PHE THR ILE SER ILE GLY GLY GLN ARG VAL THR ILE SEQRES 6 A 473 VAL GLY ASP PRO HIS GLU HIS SER ARG PHE PHE SER PRO SEQRES 7 A 473 ARG ASN GLU ILE LEU SER PRO ARG GLU VAL TYR THR ILE SEQRES 8 A 473 MET THR PRO VAL PHE GLY GLU GLY VAL ALA TYR ALA ALA SEQRES 9 A 473 PRO TYR PRO ARG MET ARG GLU GLN LEU ASN PHE LEU ALA SEQRES 10 A 473 GLU GLU LEU THR ILE ALA LYS PHE GLN ASN PHE VAL PRO SEQRES 11 A 473 ALA ILE GLN HIS GLU VAL ARG LYS PHE MET ALA GLU ASN SEQRES 12 A 473 TRP LYS GLU ASP GLU GLY VAL ILE ASN LEU LEU GLU ASP SEQRES 13 A 473 CYS GLY ALA MET ILE ILE ASN THR ALA CYS GLN CYS LEU SEQRES 14 A 473 PHE GLY GLU ASP LEU ARG LYS ARG LEU ASN ALA ARG HIS SEQRES 15 A 473 PHE ALA GLN LEU LEU SER LYS MET GLU SER SER LEU ILE SEQRES 16 A 473 PRO ALA ALA VAL PHE MET PRO TRP LEU LEU ARG LEU PRO SEQRES 17 A 473 LEU PRO GLN SER ALA ARG CYS ARG GLU ALA ARG ALA GLU SEQRES 18 A 473 LEU GLN LYS ILE LEU GLY GLU ILE ILE VAL ALA ARG GLU SEQRES 19 A 473 LYS GLU GLU ALA SER LYS ASP ASN ASN THR SER ASP LEU SEQRES 20 A 473 LEU GLY GLY LEU LEU LYS ALA VAL TYR ARG ASP GLY THR SEQRES 21 A 473 ARG MET SER LEU HIS GLU VAL CYS GLY MET ILE VAL ALA SEQRES 22 A 473 ALA MET PHE ALA GLY GLN HIS THR SER THR ILE THR THR SEQRES 23 A 473 SER TRP SER MET LEU HIS LEU MET HIS PRO LYS ASN LYS SEQRES 24 A 473 LYS TRP LEU ASP LYS LEU HIS LYS GLU ILE ASP GLU PHE SEQRES 25 A 473 PRO ALA GLN LEU ASN TYR ASP ASN VAL MET ASP GLU MET SEQRES 26 A 473 PRO PHE ALA GLU ARG CYS VAL ARG GLU SER ILE ARG ARG SEQRES 27 A 473 ASP PRO PRO LEU LEU MET VAL MET ARG MET VAL LYS ALA SEQRES 28 A 473 GLU VAL LYS VAL GLY SER TYR VAL VAL PRO LYS GLY ASP SEQRES 29 A 473 ILE ILE ALA CYS SER PRO LEU LEU SER HIS HIS ASP GLU SEQRES 30 A 473 GLU ALA PHE PRO ASN PRO ARG LEU TRP ASP PRO GLU ARG SEQRES 31 A 473 ASP GLU LYS VAL ASP GLY ALA PHE ILE GLY PHE GLY ALA SEQRES 32 A 473 GLY VAL HIS LYS CYS ILE GLY GLN LYS PHE ALA LEU LEU SEQRES 33 A 473 GLN VAL LYS THR ILE LEU ALA THR ALA PHE ARG GLU TYR SEQRES 34 A 473 ASP PHE GLN LEU LEU ARG ASP GLU VAL PRO ASP PRO ASP SEQRES 35 A 473 TYR HIS THR MET VAL VAL GLY PRO THR LEU ASN GLN CYS SEQRES 36 A 473 LEU VAL LYS TYR THR ARG LYS LYS LYS LEU PRO SER HIS SEQRES 37 A 473 HIS HIS HIS HIS HIS SEQRES 1 B 473 MET ALA LYS LYS LYS LYS LYS LYS SER PHE ASN THR THR SEQRES 2 B 473 ARG PRO THR ASP PRO PRO VAL TYR PRO VAL THR VAL PRO SEQRES 3 B 473 PHE LEU GLY HIS ILE VAL GLN PHE GLY LYS ASN PRO LEU SEQRES 4 B 473 GLU PHE MET GLN ARG CYS LYS ARG ASP LEU LYS SER GLY SEQRES 5 B 473 VAL PHE THR ILE SER ILE GLY GLY GLN ARG VAL THR ILE SEQRES 6 B 473 VAL GLY ASP PRO HIS GLU HIS SER ARG PHE PHE SER PRO SEQRES 7 B 473 ARG ASN GLU ILE LEU SER PRO ARG GLU VAL TYR THR ILE SEQRES 8 B 473 MET THR PRO VAL PHE GLY GLU GLY VAL ALA TYR ALA ALA SEQRES 9 B 473 PRO TYR PRO ARG MET ARG GLU GLN LEU ASN PHE LEU ALA SEQRES 10 B 473 GLU GLU LEU THR ILE ALA LYS PHE GLN ASN PHE VAL PRO SEQRES 11 B 473 ALA ILE GLN HIS GLU VAL ARG LYS PHE MET ALA GLU ASN SEQRES 12 B 473 TRP LYS GLU ASP GLU GLY VAL ILE ASN LEU LEU GLU ASP SEQRES 13 B 473 CYS GLY ALA MET ILE ILE ASN THR ALA CYS GLN CYS LEU SEQRES 14 B 473 PHE GLY GLU ASP LEU ARG LYS ARG LEU ASN ALA ARG HIS SEQRES 15 B 473 PHE ALA GLN LEU LEU SER LYS MET GLU SER SER LEU ILE SEQRES 16 B 473 PRO ALA ALA VAL PHE MET PRO TRP LEU LEU ARG LEU PRO SEQRES 17 B 473 LEU PRO GLN SER ALA ARG CYS ARG GLU ALA ARG ALA GLU SEQRES 18 B 473 LEU GLN LYS ILE LEU GLY GLU ILE ILE VAL ALA ARG GLU SEQRES 19 B 473 LYS GLU GLU ALA SER LYS ASP ASN ASN THR SER ASP LEU SEQRES 20 B 473 LEU GLY GLY LEU LEU LYS ALA VAL TYR ARG ASP GLY THR SEQRES 21 B 473 ARG MET SER LEU HIS GLU VAL CYS GLY MET ILE VAL ALA SEQRES 22 B 473 ALA MET PHE ALA GLY GLN HIS THR SER THR ILE THR THR SEQRES 23 B 473 SER TRP SER MET LEU HIS LEU MET HIS PRO LYS ASN LYS SEQRES 24 B 473 LYS TRP LEU ASP LYS LEU HIS LYS GLU ILE ASP GLU PHE SEQRES 25 B 473 PRO ALA GLN LEU ASN TYR ASP ASN VAL MET ASP GLU MET SEQRES 26 B 473 PRO PHE ALA GLU ARG CYS VAL ARG GLU SER ILE ARG ARG SEQRES 27 B 473 ASP PRO PRO LEU LEU MET VAL MET ARG MET VAL LYS ALA SEQRES 28 B 473 GLU VAL LYS VAL GLY SER TYR VAL VAL PRO LYS GLY ASP SEQRES 29 B 473 ILE ILE ALA CYS SER PRO LEU LEU SER HIS HIS ASP GLU SEQRES 30 B 473 GLU ALA PHE PRO ASN PRO ARG LEU TRP ASP PRO GLU ARG SEQRES 31 B 473 ASP GLU LYS VAL ASP GLY ALA PHE ILE GLY PHE GLY ALA SEQRES 32 B 473 GLY VAL HIS LYS CYS ILE GLY GLN LYS PHE ALA LEU LEU SEQRES 33 B 473 GLN VAL LYS THR ILE LEU ALA THR ALA PHE ARG GLU TYR SEQRES 34 B 473 ASP PHE GLN LEU LEU ARG ASP GLU VAL PRO ASP PRO ASP SEQRES 35 B 473 TYR HIS THR MET VAL VAL GLY PRO THR LEU ASN GLN CYS SEQRES 36 B 473 LEU VAL LYS TYR THR ARG LYS LYS LYS LEU PRO SER HIS SEQRES 37 B 473 HIS HIS HIS HIS HIS HET HEM A1450 43 HET TPF A1460 22 HET HEM B1450 43 HET TPF B1460 22 HETNAM HEM PROTOPORPHYRIN IX CONTAINING FE HETNAM TPF 2-(2,4-DIFLUOROPHENYL)-1,3-DI(1H-1,2,4-TRIAZOL-1-YL) HETNAM 2 TPF PROPAN-2-OL HETSYN HEM HEME HETSYN TPF FLUCONAZOLE; ALPHA-(2,4-DIFLUOROPHENYL)-ALPHA-(1H-1,2, HETSYN 2 TPF 4-TRIAZOLE-1-YLMETHYL)-1H-1,2,4-TRIAZOLE-1-ETHANOL; HETSYN 3 TPF ELAZOR; TRIFLUCAN; BIOZOLENE FORMUL 3 HEM 2(C34 H32 FE N4 O4) FORMUL 4 TPF 2(C13 H12 F2 N6 O) FORMUL 7 HOH *429(H2 O) HELIX 1 1 THR A 38 PHE A 48 1 11 HELIX 2 2 ASN A 51 LEU A 63 1 13 HELIX 3 3 ASP A 82 HIS A 84 5 3 HELIX 4 4 GLU A 85 SER A 91 1 7 HELIX 5 5 PRO A 99 THR A 104 1 6 HELIX 6 6 MET A 106 GLY A 111 1 6 HELIX 7 7 PRO A 121 LEU A 134 1 14 HELIX 8 8 ASN A 141 TRP A 158 1 18 HELIX 9 9 LEU A 167 PHE A 184 1 18 HELIX 10 10 GLY A 185 LEU A 192 1 8 HELIX 11 11 ASN A 193 LYS A 203 1 11 HELIX 12 12 ILE A 209 LEU A 219 1 11 HELIX 13 13 CYS A 229 GLU A 250 1 22 HELIX 14 14 ASP A 260 ALA A 268 1 9 HELIX 15 15 SER A 277 HIS A 309 1 33 HELIX 16 16 ASN A 312 ASP A 324 1 13 HELIX 17 17 ASN A 331 GLU A 338 1 8 HELIX 18 18 MET A 339 ASP A 353 1 15 HELIX 19 19 SER A 383 HIS A 388 1 6 HELIX 20 20 ALA A 417 LYS A 421 5 5 HELIX 21 21 GLY A 424 GLU A 442 1 19 HELIX 22 22 LEU A 466 GLN A 468 5 3 HELIX 23 23 THR B 38 PHE B 48 1 11 HELIX 24 24 ASN B 51 LEU B 63 1 13 HELIX 25 25 ASP B 82 HIS B 84 5 3 HELIX 26 26 GLU B 85 SER B 91 1 7 HELIX 27 27 MET B 106 GLY B 111 1 6 HELIX 28 28 VAL B 114 ALA B 118 5 5 HELIX 29 29 PRO B 121 THR B 135 1 15 HELIX 30 30 ILE B 136 GLN B 140 5 5 HELIX 31 31 ASN B 141 TRP B 158 1 18 HELIX 32 32 LEU B 167 PHE B 184 1 18 HELIX 33 33 GLY B 185 LEU B 192 1 8 HELIX 34 34 ASN B 193 LEU B 201 1 9 HELIX 35 35 ILE B 209 ARG B 220 1 12 HELIX 36 36 GLN B 225 LYS B 249 1 25 HELIX 37 37 ASP B 260 LYS B 267 1 8 HELIX 38 38 SER B 277 HIS B 309 1 33 HELIX 39 39 ASN B 312 ASP B 324 1 13 HELIX 40 40 ASN B 331 GLU B 338 1 8 HELIX 41 41 MET B 339 ASP B 353 1 15 HELIX 42 42 SER B 383 HIS B 388 1 6 HELIX 43 43 ALA B 417 LYS B 421 5 5 HELIX 44 44 GLY B 424 GLU B 442 1 19 HELIX 45 45 LEU B 466 GLN B 468 5 3 SHEET 1 AA 6 VAL A 34 PRO A 36 0 SHEET 2 AA 6 VAL A 67 SER A 71 1 O THR A 69 N TYR A 35 SHEET 3 AA 6 ARG A 76 VAL A 80 -1 O VAL A 77 N ILE A 70 SHEET 4 AA 6 ILE A 379 CYS A 382 1 O ILE A 379 N THR A 78 SHEET 5 AA 6 VAL A 359 VAL A 363 -1 O VAL A 359 N CYS A 382 SHEET 6 AA 6 LEU A 97 SER A 98 -1 O SER A 98 N MET A 362 SHEET 1 AB 3 GLU A 162 ASN A 166 0 SHEET 2 AB 3 LEU A 470 ARG A 475 -1 O VAL A 471 N ILE A 165 SHEET 3 AB 3 TYR A 443 LEU A 447 -1 O ASP A 444 N THR A 474 SHEET 1 AC 2 VAL A 367 VAL A 369 0 SHEET 2 AC 2 TYR A 372 VAL A 374 -1 O TYR A 372 N VAL A 369 SHEET 1 AD 2 PRO A 455 ASP A 456 0 SHEET 2 AD 2 GLY A 463 PRO A 464 -1 O GLY A 463 N ASP A 456 SHEET 1 BA 6 VAL B 34 VAL B 37 0 SHEET 2 BA 6 VAL B 67 ILE B 72 1 O THR B 69 N TYR B 35 SHEET 3 BA 6 GLN B 75 VAL B 80 -1 O GLN B 75 N ILE B 72 SHEET 4 BA 6 ILE B 379 CYS B 382 1 O ILE B 379 N THR B 78 SHEET 5 BA 6 VAL B 359 VAL B 363 -1 O VAL B 359 N CYS B 382 SHEET 6 BA 6 LEU B 97 SER B 98 -1 O SER B 98 N MET B 362 SHEET 1 BB 3 GLU B 162 ASN B 166 0 SHEET 2 BB 3 LEU B 470 ARG B 475 -1 O VAL B 471 N ILE B 165 SHEET 3 BB 3 TYR B 443 LEU B 447 -1 O ASP B 444 N THR B 474 SHEET 1 BC 2 VAL B 367 VAL B 369 0 SHEET 2 BC 2 TYR B 372 VAL B 374 -1 O TYR B 372 N VAL B 369 SHEET 1 BD 2 PRO B 455 ASP B 456 0 SHEET 2 BD 2 GLY B 463 PRO B 464 -1 O GLY B 463 N ASP B 456 LINK SG CYS A 422 FE HEM A1450 1555 1555 2.32 LINK FE HEM A1450 N5 TPF A1460 1555 1555 2.06 LINK SG CYS B 422 FE HEM B1450 1555 1555 2.42 LINK FE HEM B1450 N5 TPF B1460 1555 1555 2.13 CISPEP 1 TYR A 120 PRO A 121 0 -0.75 CISPEP 2 TYR B 120 PRO B 121 0 0.37 SITE 1 AC1 24 TYR A 103 TYR A 116 LEU A 127 LEU A 134 SITE 2 AC1 24 ALA A 288 ALA A 291 GLY A 292 THR A 295 SITE 3 AC1 24 SER A 296 THR A 299 LEU A 356 VAL A 359 SITE 4 AC1 24 ARG A 361 GLY A 414 PHE A 415 GLY A 416 SITE 5 AC1 24 HIS A 420 CYS A 422 ILE A 423 ALA A 428 SITE 6 AC1 24 TPF A1460 HOH A2212 HOH A2214 HOH A2215 SITE 1 AC2 11 TYR A 103 MET A 106 TYR A 116 ALA A 287 SITE 2 AC2 11 PHE A 290 ALA A 291 LEU A 356 HEM A1450 SITE 3 AC2 11 HOH A2214 HOH A2216 HOH A2217 SITE 1 AC3 22 TYR B 103 TYR B 116 LEU B 127 ALA B 288 SITE 2 AC3 22 ALA B 291 GLY B 292 THR B 295 SER B 296 SITE 3 AC3 22 THR B 299 LEU B 356 VAL B 359 ARG B 361 SITE 4 AC3 22 GLY B 414 PHE B 415 GLY B 416 HIS B 420 SITE 5 AC3 22 CYS B 422 ILE B 423 GLY B 424 TPF B1460 SITE 6 AC3 22 HOH B2035 HOH B2211 SITE 1 AC4 9 TYR B 103 PHE B 110 TYR B 116 ALA B 287 SITE 2 AC4 9 ALA B 291 LEU B 356 HEM B1450 HOH B2035 SITE 3 AC4 9 HOH B2212 CRYST1 69.993 101.472 74.729 90.00 111.63 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014287 0.000000 0.005665 0.00000 SCALE2 0.000000 0.009855 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014395 0.00000 MTRIX1 1 0.539510 -0.275260 0.795710 16.46348 1 MTRIX2 1 -0.254670 -0.954130 -0.157390 49.28086 1 MTRIX3 1 0.802540 -0.117720 -0.584870 -0.10636 1